Trends in Microbiology
ForumDetecting virulence and drug-resistance mycobacterial phenotypes in vivo
Section snippets
Bacterial phenotypes in the host
Mycobacterium tuberculosis is a successful human pathogen because of two key attributes: (i) it uses its wide range of metabolic pathways to grow, survive, or persist in greatly differing cellular and anatomic sites of infection, and (ii) it is able to produce a plethora of molecules that defend against, and selectively control, the host's immune response. These mycobacterial phenotypes determine the key host–pathogen interactions and also control drug resistance. Strong associations between
Stable-isotope tracers for investigating in situ phenotypes
The idea is simple: stable-isotope tracers can undergo specific bacterial metabolism, and the labeled products (e.g., in breath) are analyzed to indicate bacterial metabolic phenotypes. Their enzymatic nature enables rapid amplification of the signal to detectable levels. The archetype of this approach is the 13C-urea breath test for Helicobacter pylori in which a labeled urea drink is specifically delivered to the infection site (stomach) where H. pylori urease, a key virulence factor,
Concluding remarks
It is an exciting development that, by using stable-isotope breath tests, we can detect bacterial phenotypic properties, including critical drug sensitivity, in situ. The lessons learned (Box 1) will help to more generally apply this approach in order to broadly understand the complex and varied roles of bacterial metabolic phenotypes that control both host and bacterial homeostasis in asymptomatic states and overt infectious disease.
Disclaimer statement
I am co-founder and Chief Science Adviser of Avisa Pharma, a company that licenses UNM patents on products of which I am an inventor. Avisa Pharma is developing an inhaled 13C-urea breath test for diagnosing serious lung infections.
Acknowledgments
I would like to thank the many collaborators who made these studies possible and enjoyable, and the National Institutes of Health (NIH) for funding (AI063486, AI081015).
References (12)
Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection
Cell Host Microbe
(2008)Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon
J. Biol. Chem.
(2008)Tuberculosis drug resistance mutation database
PloS Med.
(2009)Bringing RNA-seq closer to the clinic
Nat. Biotechnol.
(2014)Urease activity represents an alternative pathway for Mycobacterium tuberculosis nitrogen metabolism
Infect. Immun.
(2012)Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host–pathogen interaction
J. Bacteriol.
(1995)
Cited by (3)
Potential for breath test diagnosis of urease positive pathogens in lung infections
2019, Journal of Breath ResearchStable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature
2016, Expert Opinion on Therapeutic Patents